The RheumNow Week in Review – Lupus in the News (7.27.18) Save
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com.
- ARD reports 384 Seropositive RA patients from the IMPROVED study were followed; those who become seronegative over the first year of treatment did not have a better chance of drug-free remission https://t.co/RW8NxPmsdU
- FDA grants orphan drug status to lenabasum (cannabinoid receptor agonist) for dermatomyositis https://t.co/moiw3jCqyi
- Pain in DISH is usually not from DISH; Likely another cause/problem. Pts usually asymptomatic but may complain of thoracolumbar or neck stiffness. DISH is a bone-forming diathesis primarily affecting the spine, with ossification of tendons and ligaments. https://t.co/Osir0EVJ14
- Limited data on pregnancy outcomes with tofacitinib exposure encouraging. In RA , 47 women, 44 men exposed, w/ 1 congenital defect. https://t.co/Nti7w4ZscU In UC studies 11 maternal and 14 paternal exposures w/ no congenital malformations https://t.co/qOnzopZkB3
- Cohort of 214 criteria proven antiphospholipid syndrome (APS) pts; after excluding 85 w/ >=1 SLE feature, 8 w/ CTD, 21 w/ ANA>1/320; leaves 100 with primary APS. None developed Lupus after 12 yrs F/U, yet 28% had >3 SLICC criteria https://t.co/qIDhRb1bYt
- According 2018 Medscape RESIDENTS Salary and debt report, Rheumatology Fellows are 2nd best paid (Allergy/Immunology 1st) making average of $66,200 - better than surgery, GI, critical care. 47% have >$200K med school debt. https://t.co/fMf0Zxuj0R
- Among 147 SLE patients from Denmark, half (74) had lupus nephritis (LN). LN pts with reduced renal function (<70cc/min) were 6 times more likely to have coronary artery calcifications and carotid plaque. https://t.co/jT1ovQiniu
- Study of 84 GCA & Takayasu's pts assessed w/ MRA vs PET scans showing complementary info. 60% agreement betw the two in Dz extent; 68% in Dz activity. MRA better captures disease extent, and PET scan is better suited to assess vascular activity.. https://t.co/RjtxxXAzsa
- Lancet: Baricitinib Effective in SLE Trial
- Predicting Autoimmune Progression in ANA+ Patients
- Erectile Dysfunction in Gout
- Consensus Guidelines for Methotrexate in Juvenile Idiopathic Arthritis
- Latin American Clinical Practice Guidelines for Lupus
ADD THE FIRST COMMENT
Disclosures
The author has received compensation as an advisor or consultant on this subject
If you are a health practitioner, you may Login/Register to comment.
Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.